LL-37 Australia | Antimicrobial Research Peptide
LL-37 is a synthetic cathelicidin-derived peptide widely referenced in scientific literature examining host-defence and antimicrobial activity pathways. As one of the most studied immune-research peptides available in Australia, LL-37 is cited across investigations into innate immunity and cellular signalling.
LL-37 is supplied in a 10mg strength as a lyophilised powder with third-party verification.
What Is LL-37?
LL-37 is the active fragment of human cathelicidin (hCAP18) and the only cathelicidin-derived antimicrobial peptide identified in humans. In published literature it is frequently referenced as a subject of investigation into innate immune response, antimicrobial and antibiofilm activity, angiogenesis, and epithelial repair. Its broad research profile makes it a common comparator in academic and preclinical studies exploring host-defence peptides.
LL-37 Specifications
Peptide: LL-37
Strength: 10mg
Form: Lyophilised powder
Purity: 99%+
Verification: COA provided & independently tested
Storage: Store at 2–8°C
Quality & Testing
Every batch supplied by Pureform Labs is independently analysed by a third-party laboratory for identity and purity. A Certificate of Analysis (COA) is available for each product so researchers can verify what they receive. View current lab results on our Lab Results page.
Ordering LL-37 in Australia
LL-37 is held in local Australian stock and dispatched same day on orders placed before cut-off, with tracked delivery nationwide. On arrival, store the lyophilised powder refrigerated at 2–8°C, away from light, to maintain stability.
Disclaimer: This product is intended strictly for laboratory research use only. It is not for human or animal consumption, and not for diagnostic or therapeutic use.
